NIH-Biomarkers for Early Detection of Hematopoietic Malignancies (R21)
Event details
| Date | 07.09.2015 |
| Speaker | NIH Agency |
| Category | Call for proposal |
This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), encourages research projects for the development and validation of biomarkers for: a) early detection, prediction of progression, and recurrence of hematopoietic malignancies, especially in high-risk individuals; and, b) for risk assessment of primary and secondary hematopoietic malignancies. This FOA is also encourages the development and improvement of specific technologies and methods for quantitative detection of novel biomarkers associated with hematopoietic malignancies.
Practical information
- General public
- Free